Brevan Howard Capital Management LP 10x Genomics, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 25,610 shares of TXG stock, worth $370,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,610Holding current value
$370,064% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
97.3MCall Options Held
263KPut Options Held
85.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$173 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$159 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.48MShares$93.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$92.4 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$92.1 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.37B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...